1. Characterization of a novel KDM1A/LSD1 inhibitor DDP_38003 in preclinical models of human and murine acute myeloid leukemia. (December 2016) Authors: Mercurio, C.; Botrugno, O.A.; Brambillasca, S.; Cera, M.; Cappa, A.; Dal Zuffo, R.; Dessanti, P.; Meroni, G.; Thaler, F.; Trifirò, P.; Villa, M.; Minucci, S.; So, E.C.W.; Varasi, M.; Vianello, P. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. New reversible inhibitors of histone lysine demethylase (KDM1A/LSD1). From high throughput screening to the identification of low nanomolar inhibitors with cellular activity. (December 2016) Authors: Vianello, P.; Sartori, L.; Amigoni, F.; Cappa, A.; Faga', G.; Mattevi, A.; Meroni, G.; Moretti, L.; Pasqualato, S.; Cecatiello, V.; Romussi, A.; Trifiro', P.; Varasi, M.; Villa, M.; Minucci, S.; Vultaggio, S.; Zagarri, E.; Mercurio, C. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pharmacological screening identified promising combination partners in marginal zone lymphoma models with secondary resistance to BTK and PI3K inhibitors. (October 2022) Authors: Arribas, A.; Vultaggio, S.; Andronache, A.; Robusto, M.; Fancelli, D.; Cannas, E.; Spriano, F.; Tarantelli, C.; Rossi, D.; Zucca, E.; Stathis, A.; Varasi, M.; Mercurio, C.; Bertoni, F. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗